Skip to main content
Swing Capital

Anthem Biosciences Ltd

NSE: ANTHEM BSE: 544449

Incorporated in 2006, Anthem Biosciences Ltd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients.[1]

₹787
52W: ₹579 — ₹874
PE 73.6 · Book ₹50.8 · +1449% vs book
Market Cap₹44,193 Cr
Stock P/E73.6Price to Earnings
ROCE30.7%Return on Capital
ROE23%Return on Equity
Div. Yield0%Face Value ₹2

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 21.9%

Weaknesses

  • −Stock is trading at 15.4 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend

Shareholding Pattern

Promoters74.67%
FIIs1.28%
DIIs11.55%
Public12.48%
CategorySep 2025Dec 2025Mar 2026
Promoters74.69%74.69%74.67%▼0.0
FIIs1.66%1.37%▼0.31.28%▼0.1
DIIs7.21%7.6%▲0.411.55%▲4.0
Public16.42%16.34%▼0.112.48%▼3.9

Financial Statements

MetricSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales525498479538552417
Expenses324331281343327254
Operating Profit201167198195226163
OPM %38%33%41%36%41%39%
Net Profit170128123148198112
EPS ₹3.052.292.192.643.532

AI Insights

Revenue Trend

TTM revenue at ₹1,986Cr, up 7.9% YoY. OPM at 39%.

Debt Position

Borrowings at ₹110Cr. Debt-to-equity ratio: 0.04x. Healthy balance sheet.

Capex Cycle

CWIP at ₹81Cr (13% of fixed assets). Moderate ongoing capital expenditure.

Margin & Efficiency

ROCE improving from 0% (Mar 2019) to 31% (Mar 2025). Working capital days: 128.

Valuation

PE 73.6x with 30.7% ROCE. Price is 1449% above book value of ₹50.8. Dividend yield: 0%.

Recent Announcements